Since 2102, the European School for Advanced Studies in Ophthalmology (ESASO) produces the ESASO Course Series. These books are meant as “advanced introductions”. They provide the content of expert presentations during ESASO modules on subspecialties such as retina, cataract, orbital surgery, cornea and refractive surgeries – and makes them available in print.
Series editors Francesco Bandello and Borja Corcóstegui take care that the evidence-based books not only contain preparatory and approved learning material for module participants, but are also useful as works of reference for established ophthalmologists. The volumes include personal experience and full teaching acumen, thus the ESASO Course Series become a device to give practical support to the reader.
NEW VOLUME: OCULAR TUMORS
Oncology is developing at a breathtaking pace, and so is ocular oncology. Ever more sophisticated scientific insights have emerged over the last decade, as well as advanced and technically demanding diagnostic procedures and treatments.
The new book, Ocular Tumors, provides a reliable and comprehensive review of intraocular tumors. Under the editorial leadership of volume editors Arun D Singh and Stefan Seregard, it is written by foremost experts in the field.
Ocular tumors are uncommon and diverse. But being able to recognise them, and to differentiate them from other disorders with a similar appearance is a required skill for every ophthalmologist. Prompt recognition and referral to a specialised centre have a profound impact on the final outcome. Unfortunately, eye tumors are often confused with more frequent but less serious entities. Therefore, access to a reliable and easy-to-use ‘tumor book’ seems essential.
An introductory chapter on examination techniques is followed by 10 specialised chapters on topics such as melanocytic uveal tumors, non-melanocytic uveal tumors, intraocular vascular tumors, intraocular metastases and retinoblastoma, among others. The focus of the easy-to-read and well-illustrated book is on diagnosis, often with a progression from everyday equipment and examination techniques to highly advanced machinery and expertise.
Important treatment aspects are also covered. Thus, the book is a valuable resource for primary care ophthalmologists as well as residents and fellows in the field of ophthalmology.
The next volume in the series will cover the latest state-of-the-art advances in glaucoma diagnosis and treatment. It will be edited by Prof Carlo Enrico Traverso and is due in the autumn. It will be a useful manual with practical considerations based on evidence and consensus. The contributing authors are renowned experts in the specialty of glaucoma.
ESASO Course Series books are published by the leading biomedical publisher S Karger AG (Basel, Switzerland). 
The books are available in print and electronically.
Further information is available on the publisher’s website at: 
www.karger.com/esaso
Latest Articles
Simulators Benefit Surgeons and Patients
Helping young surgeons build confidence and expertise.
Read more...
Diamonds in the Rough
The push for inclusivity in ophthalmology.
Read more...
Making Female Leadership More than a Moment
A remarkable global confluence of women in key positions.
Read more...
ESCRS Talks Technology at AAO
Europe adopts technological advances, US still waiting for lenses and lasers.
Read more...
Sorting Out Simultaneous Vision IOLs
The ESCRS Eye Journal Club discuss a new landmark paper on IOL classification and the need for harmonisation of terminology for presbyopic IOLs.
Read more...
Big Advantages to Small-Aperture IOLs
Small-aperture IOLs offer superior image quality with increased range of focus.
Read more...
Prioritising Self-Care
Benefits of maintaining physical, emotional, and mental health extend beyond the personal sphere.
Read more...
Valuing Clinical Trial Design
How inclusivity and diversity can enhance scientific accuracy in research.
Read more...
Knowing Iris Repair: Using Iridodiathermy in Iris Surgery
Prepare for decentred pupils and uneven irides in multiple situations.
Read more...
Neuroprotectant Treatment for MacTel Type 2
Intravitreal implant releasing ciliary neurotrophic factor found safe and effective in pivotal trials.
Read more...